Podcasts about Gaga

Wesley Morris didn't love Lady Gaga's new album “Mayhem.” Then Caryn Ganz, The Times's pop music editor, took him to see Mayhem — the tour — on its final night at Madison Square Garden. It totally changed the way both of them think about Gaga and what she's been up to all this time. In short: All hail Mother Monster. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

This week on Sibling Rivalry, Bob is ready to fight everyone. They discuss the origins of the Romance languages and the difference between Nordic and Scandinavian countries before diving into family prayers, gratitude lists, and a crafty nun story. They discuss the dance stamina of Britney Spears, Gaga, and Beyoncé, then test each other's memory on tattoos, quiz one another on culinary terms, debate whether eggs count as dairy, and determine the ideal consistency for dunking an Oreo. Stop putting off those doctors appointments and go to https://Zocdoc.com/RIVALRY to find and instantly book a top-rated doctor today! Learn more about your ad choices. Visit podcastchoices.com/adchoices

In episode 388 UNP founder and curator Grant Scott is in his shed reflecting on the big and small things that impact on the everyday engagement we all have with photography. https://www.artsy.net/article/addicted-art-gallery-markus-klinko-lady-gaga-hello-kitty Dr.Grant Scott After fifteen years art directing photography books and magazines such as Elle and Tatler, Scott began to work as a photographer for a number of advertising and editorial clients in 2000. Alongside his photographic career Scott has art directed numerous advertising campaigns, worked as a creative director at Sotheby's, art directed foto8magazine, founded his own photographic gallery, edited Professional Photographer magazine and launched his own title for photographers and filmmakers Hungry Eye. He founded the United Nations of Photography in 2012, and is now a Senior Lecturer and Subject Co-ordinator: Photography at Oxford Brookes University, Oxford, and a BBC Radio contributor. Scott is the author of Professional Photography: The New Global Landscape Explained (Routledge 2014), The Essential Student Guide to Professional Photography (Routledge 2015), New Ways of Seeing: The Democratic Language of Photography (Routledge 2019), and What Does Photography Mean To You? (Bluecoat Press 2020). His photography has been published in At Home With The Makers of Style (Thames & Hudson 2006) and Crash Happy: A Night at The Bangers (Cafe Royal Books 2012). His film Do Not Bend: The Photographic Life of Bill Jay was premiered in 2018. Scott's book Inside Vogue House: One building, seven magazines, sixty years of stories, Orphans Publishing, is now on sale. https://www.eventbrite.co.uk/e/a-photographic-live-live-2025-tickets-1693780716719?aff=oddtdtcreator © Grant Scott 2025

In Episode 140, astrologers Kristina Martin and Tara Redfield turn their cosmic gaze to pop music's famous star, Lady Gaga, and her venture capitalist fiancé, Michael Polansky.   The analysis begins with Gaga's chart, revealing a creative, pioneering Aries Sun. A trine to Saturn shows her resilience in the face of setbacks, while a square from Neptune fuels her deep compassion and fluid sense of identity. Her Aries Venus, trined by Uranus, points to a fearless and uniquely rebellious style.   Moving to Michael's chart, we find an equality-oriented Libra Sun, with a sextile from Uranus and Jupiter creating an incredibly outgoing and charming personality. A Venus/Mars conjunction in Leo thrives in the spotlight, though a square from the Moon suggests potential difficulties in interpersonal relationships.   Together, their charts reveal compelling synastry: one is Mars-ruled, the other Venus-ruled, with opposing Suns creating complimentary energy. A Mercury opposition balances imagination and diligence, while an incredible Venus/Mars trine generates never-ending attraction. However, a Venus/Pluto opposition warns of potential power struggles, and heavy south node contacts with Saturn and Uranus indicate significant karmic lessons at play. Will this prove to be a lasting union? Tune in to hear the final Venus score for this newly engaged couple!   Book a Reading with us! Connect with Kristina Martin Book a Reading www.klmastrology.com astrologyklm@gmail.com www.instagram.com/klmastrology   Connect with Tara Redfield Book a Reading www.anotherdaygreener.com anotherdaygreener@gmail.com www.instagram.com/anotherdaygreener/ www.tiktok.com/@anotherdaygreener

Artisten Lady Gaga är just nu i Sverige för tre utsålda konserter i Globen kritikerna hyllar hennes maximalistiska allkonstverk med femmor i betyg. Lyssna på alla avsnitt i Sveriges Radio Play. Samtal med kritikerna Markus Larsson, Aftonbladet, och Johanna Paulsson, Dagens nyheter om varför Lady Gaga lyckas med ”The Mayhem Ball” och vart artisten är på väg.WAGNER-VETERANEN CHARLOTTE ENGELKES SÄTTER UPP SIN FÖRSTA WAGNEROPERASom scenkonstnär har Charlotte Engelkes gjort sig känd för att återkommande undersöka och bearbeta Wagner. Nu sätter hon för första gången upp en Wagner-opera i sin helhet, nästa vecka har hennes Lohengrin premiär på Malmö Opera – idag är hon gäst i P1 Kultur.HUR NÄRMAR VI OSS ANTISEMITEN WAGNER?Wagner har en dokumenterad och välkänd historia av judehat, till exempel i skriften ”Judendomen i musiken” där han argumenterar – på rasbiologisk grund – för att Felix Mendelssohn och andra judiska tonsättare har en degenererande inverkan på lyssnarna, men också genom antisemitiska idéer och figurer i hans verk. Hur ska vi idag, mer än 150 år senare, förhålla oss till det? Samtal med Björn Wiman, kulturchef Dagens nyheter.REVOLTERANDE KVINNOR: MONIKA FAGERHOLM TILLBAKA MED FÖRSTA DELEN I NY TRILOGI"Döda trakten/ Kvinnor i revolt" - så heter finlandssvenska Monika Fagerholms nya bok – en roman som placerar sig mitt i det fagerholmska litterära landskapet, så som hennes läsare lärt känna det. Samtal med P1 Kultur kritiker Lina Kalmteg. ESSÄ: DUBELGÅNGARE – MANLIGA MÖRKERFIGURER GÅR IGEN Dubbelgångare är vanliga i litteraturen sedan 1800-talet. Men de verkar livskraftiga och har fått nytt liv i den moderna tv-serien. Gabriella Håkansson har en teori om varför.Programledare: Lisa WallProducent: Eskil Krogh Larsson

JCO PO author Dr. Asaf Maoz at Dana-Farber Cancer Institute shares insights into article, “Causes of Death Among Individuals with Lynch Syndrome in the Immunotherapy Era.” Host Dr. Rafeh Naqash and Dr. Maoz discuss the causes of death in individuals with LS and the evolving role of immunotherapy. TRANSCRIPT Dr. Rafeh Naqash: Hello, and welcome to JCO Precision Oncology Conversations, where we bring you engaging conversations with authors of clinically relevant and highly significant JCOPO articles. I'm your host, Dr. Rafeh Naqash, podcast editor for JCO Precision Oncology and Associate Professor Medicine, at the OU Health Stephenson Cancer Center. Today, I'm super thrilled to be joined by Dr. Asaf Maoz, Medical Oncologist at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and faculty at the Harvard Medical School, and also lead author on the JCO Precision Oncology article entitled "Causes of Death Among Individuals with Lynch Syndrome in the Immunotherapy Era." This publication will be a concurrent publication with an oral presentation at the annual CGA meeting. At the time of this recording, our guest's disclosures will be linked in the transcript. Asaf, I'm excited to welcome you on this podcast. Thank you for joining us today. Dr. Asaf Maoz: Thank you so much for highlighting our paper. Dr. Rafeh Naqash: Absolutely. And I was just talking to you that we met several years back when you were a trainee, and it looks like you've worked a lot in this field now, and it's very exciting to see that you consider JCOPO as a relevant home for some of your work. And the topic that you have published on is of significant interest to trainees from a precision medicine standpoint, to oncologists in general, covers a lot of aspects of immunotherapy. So, I'm really excited to talk to you about all of this. Dr. Asaf Maoz: Me too, me too. And yeah, I think JCOPO has great content in the area of cancer genetics and has done a lot to disseminate the knowledge in that area. Dr. Rafeh Naqash: Wonderful. So, let's get started and start off, given that we have hosts of different kinds of individuals who listen to this podcast, especially when driving from home to work or back, for the sake of making everything simple, can we start by asking you what is Lynch syndrome? How is it diagnosed? What are some of the main things to consider when you're trying to talk an individual where you suspect Lynch syndrome? Dr. Asaf Maoz: Lynch syndrome is an inherited predisposition to cancer, and it is common. So, we used to think that, or there's a general notion in the medical community that it is a rare condition, but we actually know now from multiple studies, including studies that look at the general population and do genetic testing regardless of any clinical phenotype, that Lynch syndrome is found in about 1 in 300 people in the general population. If you think about it in the United States, that means that there are over a million people living with Lynch syndrome in the United States. Unfortunately, most individuals with Lynch syndrome don't know they have Lynch syndrome at the current time, and that's where a lot of the efforts in the community are being made to help detect more individuals who have Lynch syndrome. Lynch syndrome is caused by pathogenic germline variants in mismatch repair genes, MLH1, MSH2, MSH6, or PMS2, or as a result of pathogenic variants in EPCAM that cause silencing of the MSH2 gene. Dr. Rafeh Naqash: Excellent. Thank you for that explanation. Now, one of the other things I also realized, similar to BRCA germline mutations, where you require a second hit for individuals with Lynch syndrome to have mismatch repair deficient cancers, you also require a second hit to have that second hit result in an MSI-high cancer. Could you help us understand the difference of these two concepts where generally Lynch syndrome is thought of to be cancers that are mismatch repair deficient, but that's not necessarily true for all cases as we see in your paper. Can you tease this out for us a little bit more? Dr. Asaf Maoz: Of course, of course. So, the germline defect is in one of the mismatch repair genes, and these genes are responsible for DNA mismatch repair, as their name implies. Now, in a normal cell, we think that one working copy is generally enough to maintain the mismatch repair machinery intact. What happens in tumors, as you alluded to, is that there is a second hit in the same mismatch repair gene that has the pathogenic germline variant, and that causes the mismatch repair machinery not to work anymore. And so what happens is that there is formation of mutations in the cancer cell that are not present in other cells in the body. And we know that there are specific types of mutations that are associated with defects in mismatch repair mechanisms, and those are associated a lot of times with frameshift mutations. And we have termed them ‘microsatellites'. So there are areas in the genome that have repeats, for example, you know, if you have AAAA or GAGA, and those areas are particularly susceptible to mutations when the mismatch repair machinery is not working. And so we can measure that with DNA microsatellite instability testing. But we can also get a sense of whether the mismatch repair machinery is functioning by looking at protein expression on the surface of cancer cells and by doing immunohistochemistry. More recently, we're also able to infer whether the mismatch repair machinery is working by doing next-generation sequencing and looking at many, many microsatellites and whether they have this DNA instability in the microsatellites. Dr. Rafeh Naqash: Excellent explanation. As a segue to what you just mentioned, and this reminds me of some work that one of my good friends, collaborators, Amin Nassar, whom you also know, I believe, had done a year and a half back, was published in Cancer Cell as a brief report, I believe, where the concept was that when you look at these mismatch repair deficient cancers, there is a difference between NGS testing, IHC testing, and maybe to some extent, PCR testing, where you can have discordances. Have you seen that in your clinical experience? What are some of your thoughts there? And if a trainee were to ask, what would be the gold standard to test individuals where you suspect mismatch repair deficient-related Lynch syndrome cancers? How would you test those individuals? Dr. Asaf Maoz: We do sometimes see discordance, you know, from large series, the concordance rate is very high, and in most series it's over 95%. And so from a practical perspective, if we're thinking about the recommendation to screen all colorectal cancer and all endometrial cancer for mismatch repair deficiency, I think either PCR-based testing or immunohistochemistry is acceptable because the concordance rate is very high. There are rare cases where it is not concordant, doing multiple of the tests makes sense at that time. If you think about the difference between the tests, the immunohistochemistry looks at protein expression, which is a surrogate for whether there is mismatch repair deficiency or not, right? Because ultimately, the mismatch repair deficiency is manifested in the mutations. So if the PCR does not show microsatellite instability and now NGS does not show microsatellite instability, the IHC may be a false positive. At the end of the day, the functional analysis of whether there are actually unstable microsatellites either by PCR or by NGS is what I would consider more informative. But IHC again is an excellent test and concordant with those results in over 95% of cases. Now there is also an issue of sampling. It's possible that there's heterogeneity within the tumor. We published a case in JCOPO about heterogeneity of the mismatch repair status, and that was both by immunohistochemistry, but also by PCR. So there are some caveats and interpreting these tests does require some expertise, and I'm always happy to chat with trainees or whoever has an interesting or challenging case. Dr. Rafeh Naqash: Thanks again for that very easy to understand explanation. Now going to management strategies, could you elaborate a little bit upon the neo-adjuvant data currently, or the metastatic data which I think more people are familiar with for immunotherapy in individuals with MSI-high cancers? Dr. Asaf Maoz: Yeah, that's an excellent question and obviously a very broad topic. Individuals with Lynch syndrome typically develop tumors that are mismatch repair deficient or microsatellite unstable. And we have seen over the last 15 years or so that these tumors, because they have a lot of mutations and because these mutations are very immunogenic, we have seen that they respond very well to immunotherapy. And this has been shown across disease sites and has been shown across disease settings. And for that reason, immunotherapy was approved for MSI-high or mismatch repair deficient cancer regardless of the anatomic site. It was the first tissue-agnostic approval by the FDA in 2017. And so there are exciting studies both in the metastatic setting where we see individuals who respond to immunotherapy for many years, and one could wonder whether their cancer is going to come back or not. And also in the earlier setting, for example, the Cercek et al. study in the New England Journal from Sloan Kettering, where they showed that neoadjuvant immunotherapy can cause durable responses for rectal cancer that is mismatch repair deficient. And in that series, the patients did not require surgery or radiation, which is standard of care for rectal cancer otherwise. And there's also exciting data in the adjuvant space, as was presented in ASCO by Dr. Sinicrope, the ATOMIC study, and many more efforts to bring immunotherapy into the treatment landscape for individuals with MSI-high cancer, including individuals with Lynch syndrome. Dr. Rafeh Naqash: A lot of activity, especially in the neo-adjuvant and adjuvant space over the last two years or so. Now going to the actual reason why we are here is your study. Could you tell us why you looked at this idea of patients who had Lynch syndrome and died, and the reasons for their death? What was the thought that triggered this project? Dr. Asaf Maoz: As we were talking about, we now know that immunotherapy really has changed the treatment landscape for individuals with Lynch syndrome, and that most cancers that individuals with Lynch syndrome do have this mismatch repair deficiency. But we also know that individuals with Lynch syndrome can develop tumors that do not have mismatch repair deficiency, and we call them mismatch repair proficient or microsatellite stable. And there was a series from Memorial Sloan Kettering showing that in colorectal cancer, about 10% of the tumors that individuals with Lynch syndrome developed did not have mismatch repair deficiency. In addition to that, we anecdotally saw that some of our patients with Lynch syndrome died of causes that were not mismatch repair deficient tumors. We wanted to see how that has changed since immunotherapy was approved in a tissue-agnostic manner, meaning that we could look at this regardless of where the cancer started, because we would anticipate that if the tumor was mismatch repair deficient, the patient would be able to access immunotherapy as standard of care. Dr. Rafeh Naqash: Thank you. And then you looked at different aspects of correlations with regards to individuals that had an MSI-high cancer with Lynch syndrome or an MSS cancer with Lynch syndrome. Could you elaborate on some of the important findings that you identified as well as some of the unusual findings that perhaps we did not know about, even though the sample size is limited, but what were some of the unique things that you did identify through this project? Dr. Asaf Maoz: The first question was what cause is leading to death in individuals with Lynch syndrome? And we had 54 patients that we identified that had died since the approval of immunotherapy in 2017, 44 of which died of cancer-related causes. And when we looked at cancer-related causes of death, we wanted to know how many of those were due to mismatch repair deficient tumors versus mismatch repair proficient tumors or MS-stable tumors. And we found, somewhat surprisingly, that 43% of patients in our cohort actually died of tumors that were microsatellite stable or mismatch repair proficient, meaning of tumors that are not typically associated with Lynch syndrome. This is not entirely surprising as a cause of death because we know that immunotherapy does not typically work for tumors that are microsatellite stable. And so in the metastatic setting, there are much less cases of durable remissions with treatment. But it was helpful to have that figure as an important benchmark. There are previous studies about causes of death in Lynch syndrome, and particularly from the Prospective Lynch Syndrome Database in Europe. Those have provided really important information about cause of death by cancer site, but they typically don't have mismatch repair status and are more difficult to interpret in that regard. They also don't include a large number of individuals who have PMS2 Lynch syndrome, which is the most common, but least penetrant form of Lynch syndrome. Dr. Rafeh Naqash: As far as the subtype of pathogenic germline variants is concerned, did you notice anything unusual? And I've always had this question, and you may know more about this data, is: In the bigger context of immunotherapy, does the type of the pathogenic germline variant for Lynch syndrome associated MSI-high cancers, does that impact or have an association with the kind of outcomes, how soon a cancer progresses or how many exceptional responders perhaps with MSI-high cancers actually have a certain specific pathogenic germline variant? Dr. Asaf Maoz: That's an excellent question, and certainly we need more data in that space. We know that the type of germline mutation, or the gene in which there is a germline pathogenic variant, determines to a large degree the cancer risk, right? So we know that individuals who have germline pathogenic variants in MLH1 or MSH2 have a much higher colorectal cancer risk than, for example, PMS2. We know that for PMS2, the risks are more limited to colorectal and endometrial, and may be lower risk of other cancers. We also know that, you know, the spectrum of disease may change based on the pathogenic germline variants. For example, individuals who have MSH2 associated Lynch syndrome have more risk of additional cancers in other organs like the urinary tract and other less common Lynch-associated tumors. The question about response to therapy is one where we have much less information. There are studies that are trying to assess this, but I don't think the answer is there yet. Some of the non-clinical data looks at how many mutations there are based on the pathogenic variant and what the nature of those mutations are, whether they're more frameshift or others. But I think we still need more clinical data to understand whether the response to immunotherapy differs. It's also complicated by the fact that the immunotherapy landscape is changing, especially in the metastatic setting, now with the approval of combination ipilimumab and nivolumab for first-line treatment of colorectal cancer that is microsatellite unstable. But in our study, we did find that, as you would expect, there is an enrichment in MS-stable cancers among those with PMS2 Lynch syndrome. Again, our denominator is those who died, right? So this is not the best way to look at the question whether this is overall true, that is more addressed by the study that Sloan Kettering published. But we do see, as we would anticipate, that there are more microsatellite stable cancers among those with PMS2 Lynch syndrome that died. Dr. Rafeh Naqash: A lot to uncover there for sure. This study and perhaps some of the other work that you're doing is slowly advancing our understanding of some of these concepts. So I'd like to shift gears to a couple of provocative questions that I generally like to ask. The first is, in your opinion, and you may or may not have data to back this up, which is okay, and that's why we're having a conversation about it. In your opinion, do you think the type or the quality of the neoantigen is different based on the pathogenic germline variant and a Lynch syndrome associated MSI-high cancer? Dr. Asaf Maoz: I think there are some data out there that, you know, I can't cite off the top of my mind, but there are some data out there that suggest that that may be the case. I think the key question is the quality, right? I think that whether these differences that are found on a molecular level also translate to a clinical difference in response is something that is unknown at this moment. Some people hypothesize that if the tumor has less neoantigens, there's less of a response to immunotherapy. But I think we really need to be careful before making those assertions on a clinical level. I do think it's a really important question that needs to be answered, among others because, you know, in the colorectal space, for example, where we have both the option of doing ipilimumab with nivolumab and the option of doing pembrolizumab, we don't really know which patients need the CTLA-4 blockade versus which patients can receive PD-1 blockade alone and avoid the potential excess toxicity of the CTLA-4 blockade. There are a lot of interesting questions there that still need to be answered. And of course, individuals with Lynch syndrome are just a fraction of those individuals who have MSI-high cancer. So there's also the question about whether non-Lynch syndrome associated MSI-high cancer responds differently to immunotherapy than Lynch syndrome associated MSI-high cancer. A lot of very interesting questions in the field for sure. Dr. Rafeh Naqash: Absolutely. My second question is more about trying to understand the role of ctDNA, MRD monitoring in individuals with Lynch syndrome. If somebody has a germline, you know, Lynch syndrome MSI-high cancer, when you do a tumor-informed ctDNA assessment, what do you capture generally there? Because, and this question stems from a discussion I've had with somebody regarding EGFR lung cancer, since I treat individuals with lung cancer, and the concept generally is that even if the tissue showed EGFR, but for MRD monitoring, when you do a barcoded sequence of different tumor specific mutations, it's not actually the EGFR that they track in the blood when they do ctDNA assessment. But from a Lynch syndrome standpoint, if you have a germline, right, which is the first hit, and then you have the somatic in the tumor, which is the second hit, are you aware or have you tried to look into this where what is exactly being followed if one had to follow MRD in a Lynch syndrome MSI-high colorectal cancer? Dr. Asaf Maoz: I think a lot of the MRD assays are proprietary, and so we don't receive information about what the mutations that are being tracked are. In general, the idea is to track mutations that we would not expect to disappear as part of resistant mechanisms. We want these to be truncal mutations. We want these to be mutations in which resistance is not expected to result in reversion mutations. But what specifically is being tracked is something that I don't know because these assays, the tumor-informed ones, are proprietary, and we don't get the results regarding specific mutations. When it's circulating tumor DNA that is not necessarily tumor-informed, we do get those results, but that is less so about the specific selection of mutations. Dr. Rafeh Naqash: Thank you for clarifying that question to some extent, of course, as you said, we don't know a lot, and we don't know what we don't know. That's the most important thing that I've learned in the process of understanding precision medicine and genomics, and it's a very fast-paced evolving field. Last question related to your project, what is the next step? Are you planning any next steps as a bigger multicenter study or validation of some sort? Dr. Asaf Maoz: There are two big questions that this study raises. One, is this true across multiple other sites, right? Because this is a single center study, and we really need additional centers to look at their data and validate whether they are also seeing that a substantial portion of deaths in individuals with Lynch syndrome are attributable to mismatch repair proficient cancer. The other question is whether we can look at specifically MSI-high cancer versus MS-stable cancer and understand what the mortality rate for each of those are. From a clinical perspective, it's important to counsel individuals with Lynch syndrome about general cancer screening outside of mismatch repair deficient tumors and to understand that there is also a risk of mismatch repair proficient tumors and that treatment for those tumors would be different. There's a lot of work to be done in the future. Another major area of need is to see whether tumors that are microsatellite stable can be sensitized to immunotherapy, and that is beyond the Lynch syndrome field, but that is something that certainly would benefit these individuals with Lynch syndrome who develop mismatch repair proficient cancer. Dr. Rafeh Naqash: That's very interesting to hear, and we'll look forward to seeing some of those developments shape in the next few years. Now, I'd like to spend a minute, minute and a half on you specifically as a researcher, clinician, scientist. Could you briefly highlight - because I remember meeting you several years back as a trainee, with your interest in genomics, computational research - could you briefly tell us what led you to hereditary cancer syndromes based on your research and work? What are some of the things that you learned along the way that other early career investigators can perhaps take lessons from? Dr. Asaf Maoz: Big questions there, thanks for asking. I got interested in the field of hereditary cancer syndromes when I came to the United States and started doing lab research in Stephen Gruber's lab at the time at USC. He's now at City of Hope. And my interest was originally looking at immunotherapy and immunology, but I went to the case conferences where we were learning about individuals with hereditary cancer, and those were kind of earlier days where we were still trying to figure out how to test and what the implications for these individuals would be. And through fellowship, I was also very interested in that, and I did my senior fellowship years with Dr. Yurgelun here at Dana-Farber, who is the director of the Lynch Syndrome Center. And I I think it's the combination between being able to treat individuals based on precision medicine and what the germline mutation is, but also the ability to prevent cancer and to develop strategies to intercept cancer early that is really appealing to me in this field. It's also a great field to be in because it's a small field. If you come to the CGA-IGC meeting, you'll be able to interact with everyone. Everyone is super collaborative, super nice, and I really recommend it to trainees. The CGA-IGC annual meeting is really a great opportunity to learn more and experience some of the advancement specifically in the GI hereditary space. Lessons for trainees. I think there are a lot of lessons that I could think about, but I think finding strong and supportive mentors is one of the things that has helped me most. I think that just having close relationship with your mentor, having frequent discussions and honest discussions about what is feasible, what is going to make a difference for your patients and your research and what you want to focus on is really important. And so I think if I had to choose one thing, I would say choose a mentor that you trust, that you feel you have a good relationship with, and that has the availability to support you. Dr. Rafeh Naqash: Thank you so much for those insightful comments, and thank you for sharing with us your journey, your project, and some of your interesting thoughts on this concept of hereditary cancers. Hopefully, we'll see more of this work being published in JCOPO through your lab or work from others. Dr. Asaf Maoz: Thank you so much. I appreciate the opportunity to be here. Dr. Rafeh Naqash: Thank you for listening to JCO Precision Oncology Conversations. Don't forget to give us a rating or review and be sure to subscribe so you never miss an episode. You can find all ASCO shows at ASCO.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

Can they be serious? Some high profile talking heads believe they've found the cure for 'gayness' and all you need to do is ignore Gaga when she says "baby you were born this way". Today we talk Dolly Parton, Taylor Swift and Madonna who plans to release a new edition of the fantastic Bedtime Stories. We wanna know what you think. Email us at timetotalkaustralia@outlook.com And keep us on the air - spare us a dime at www.patreon.com/timetotalkaustralia  

On today's episode, we welcome the multi-talented Kim Ray, a writer, producer, and director whose career spans reality TV, documentaries, and scripted projects. Best known for her work on the Netflix documentary Gaga: Five Foot Two, Kim's journey through the industry is an inspiring tale of creativity, resilience, and innovation.Our conversation begins with Kim's fascinating experience co-writing West Bank Story, a parody of West Side Story that cleverly blended humor with themes of peace and cultural commonality. As Kim describes, “It was about showing that even in a world full of conflict, there's so much that connects us.” The project, which gained significant recognition, was a testament to her ability to merge art with meaningful messages.Kim's transition into reality television was both unexpected and transformative. While it wasn't her original focus, she brought her narrative expertise to shows like The X Factor and Kendra on Top. “Reality TV,” Kim explains, “requires storytelling that's just as nuanced as scripted work. You're shaping real moments into something cohesive and engaging.” Her work on these projects highlights her adaptability and deep understanding of human emotion.One of the standout points in Kim's career was producing Gaga: Five Foot Two. The project offered an intimate glimpse into Lady Gaga's life, showcasing her vulnerabilities and strength. Kim recounts the challenges of crafting such an unfiltered narrative, saying, “The magic was in the authenticity. Gaga was raw and real, and we wanted viewers to feel like they were walking alongside her.” The minimal crew and close collaboration created an unparalleled connection between the subject and the audience.Beyond her professional achievements, Kim's insights into the industry's evolution are enlightening. She speaks candidly about the systemic challenges women face in Hollywood, sharing how she navigated a landscape often dominated by male voices. Her reflections on the #MeToo movement underscore the importance of platforms like social media for amplifying marginalized voices. “It's a double-edged sword,” Kim notes, “but it's also a powerful tool for change.”Kim's current project, Violet's New Life, delves into the futuristic concept of consciousness transfer. The short film and pilot explore what it means to live again in a synthetic body, blending technology and human emotion. As Kim puts it, “It's not just about immortality—it's about the psychology of starting over, carrying the weight of one life into another.”Become a supporter of this podcast: https://www.spreaker.com/podcast/bulletproof-screenwriting-podcast--2881148/support.

This week on Sibling Rivalry, Bob and Monét wife-swap with No Gorge for a crossover episode — No Rivalry with Gottmik. Bob asks what it's really like working with Violet Chachki and how Mik handles fan backlash for critiquing Drag Race queens. They break down the wildest Gottmik rumors, talk new music, and The Knockout Tour with Violet. Bob recalls bringing queens on stage during the Madonna tour, tests his color blindness, and apologizes for the music video they did together. Plus, they compare fashion hits and misses, Madonna's confusion over Mik's makeup, and ask which queen is the biggest Gaga fan. Home Chef is offering my listeners 50% off and free shipping for your first box PLUS free dessert for life! Go to https://HomeChef.com/RIVALRY. Learn more about your ad choices. Visit podcastchoices.com/adchoices

"Gaga Ball" is a popular game for kids today. It's often played at church or school playgrounds. After a few days of exploring Gaga Ball, I finally came up with the most simplified game rules and a few theories on the origins of the game. This show will be helpful for homeschoolers or people working with youth. Enjoy...Ga...Ga...BALL!Gaga Ball: History & Rules Handout@mattbradfordmusic

President Trump is using the government shutdown to punish anyone who didn't vote for him, J.D. Vance loves memes so we made a special one just for him, and Stephen Colbert checks in on some well-known people who are dipping their toes in the artificial intelligence pool. Stephen Colbert heads downtown to The Bitter End, the New York City venue where Stefani Germanotta first performed as Lady Gaga. In this four-part interview, Gaga discusses her art, her career, and her newfound happiness while Stephen tries on some of the artist's far-out looks. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

The Flase Dichotomy presented by "A Katy or a Gaga" posits that Gaga is as dark and edgy as Nine Inch Nails, and Katy Perry is a bland and non-sexual entity. I - we - what?! Anyways, we're gonna spend this episode a little slap-happy as we discuss discount Rum Tum Tuggers, boob lovers of all genders, and litigating the chronology of glee. Harley can be found @IWriteQueerSins.bsky.social, and on AO3 at https://archiveofourown.org/users/Passionpire88. If you want to contact us we can be found at loserlikemepod@gmail.com, or @loserlikemepod.bsky.social on BlueSky. Tanner can be found there @SparkyUpstart, and Christina @CWoodsArt. Check out the Corner Pod Net Discord here: https://discord.gg/Hf8Y2yEJPe.

This week Danny Beard, Billy Andrew and Producer Lillie-Mae talk about the Autumn TV line-up, Danny's win at the National Diversity Awards and a listener letter shows how their housemate got to watch a full Lady Gaga performance through a ring door bell... Grab your tix to see Danny Live: thedannybeard.komi.ioWant to be a Gossip Goddess or a Question Queen and win a badge?Send us your crazy and dirty confessions! They could be your own saucy tales or the goss you have on your friends! Send them in here:Our Whatsapp is back! wa.me/447822033434Gossip Form: https://forms.gle/s1ZruNQBLxyHefym8 Hosted on Acast. See acast.com/privacy for more information.

In this episode of the Four-Eyed Professor podcast, Dr. Chris Lievens and Dr. Jessica Steen discussed how to recognize GA, how to monitor its progression, and how to guide patients through treatment discussions. Optometrists are increasingly asked not only what IZERVAY is and what it is used for, but also practical questions about how an IZERVAY eye injection works and what patients should expect.

Here is the free single "Gaga Meets The Queen Of Chromatica" from LGIS2025 Volume 137

Matthi & Henry are celebrated for their dynamic Hybrid Live performances and DJ sets. Their weekly radio show, From Techno Into Trance, showcases their ability to seamlessly blend these genres, offering listeners a masterclass in genre-fluid artistry. From Techno Into Trance 92 01 D-Unity - Feel My Body 02 ZHU - Faded (BlackliztVersion (HNTR Extended) 03 Gaga & Mateo! - Temple (Original) 04 Oscurate - 1998 (Boudi Remix) 05 Filterheadz - Aurora 06 Stoneface & Terminal - Titan 07 Len Faki & Jancen - Morgana 08 2nd Chemistry - Into The Void (Extended) 09 Lucinee - Turn On 10 SWART - Eternal Raver 11 Hertz - Fat Fingers 12 Disgused - Indigo 13 Stoneface & Terminal - Caterpillar 14 Andree Bohlin - Revival (Billie Jo Remix) 15 Push - Xennial (Techno Edit) 16 LSG - I'm Not Existing (Oliver Lieb Main Mix) 17 Kaiserdisco - Selective Perception 18 Basil O'Glue - Takeover 19 Arc In The Sky - Vainquere (Stoneface & Terminal Mix) 20 Metro Dade - The Andor Voyage (Ramon Tapia Remix) 21 Purient & Randomer - Like It (Randomer Remix) 22 F4T4L3RR0R & Tristan Dior - Fragil (Türen Remix) 23 Stoneface & Terminal - Berlin '98 (Berlin To Ibiza Mix) 24 Rank 1 - It's Up To You

Gaga won't let us rest! Is Tate the next Britney? Is Dua ever NOT on vacation? Is Cardi's press tour the greatest of all time?? And who should play the Super Bowl halftime show: Megan, Ariana, or MALALA?? PLUS: Did Cody, Andrew, and Ren survive the Rapture?? AND DWTS and Coachella 2026 reactions!!We have deals for YOU!!Kindred: Want a members only travel experience? Apply now at LiveKindred.com and use code PETTY to join for free! Plus, earn five nights of travel credit just for signing up!LMNT: Stay replenished! Get your free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at DrinkLMNT.com/tactfulQuince: Stock up on classic fall staples! Go to Quince.com/pettiness for free shipping on your order and 365-day returns!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Roz defends a mysterious cut over his eye, Maurie chats with UFC legend Georges St-Pierre & Vince Vaughn at TIFF! The Damnits were a drunken mess at the Lady Gaga concert. Plus, listeners share love from Bancroft and New Brunswick, and the crew debates whether they could recite 90% of a movie for $100K.

The crew heads back for another school year at Nevermore on the latest TV Junk Podcast. Frank, Nuno and Greg break down each episode from Season 2 of Wednesday. They discuss the need to bring back every character from Season 1, huge Addams Family lore reveals, the Gaga effect and Greg reveals the worst thing about either season of this show. Check it out here at the link below or download and subscribe wherever you find your favourite podcasts.

HAVE FUN QUEEN! Today on the show, HAPPY FRIDAY! New COUPLES THERAPY this weekend with Noah and Lenora but first PAYTON NEEDS TO DROP A FRIEND and PRESLEY MADE US LAUGH with her GOLF OPINIONS. Plus, NEW MUSIC FRIDAY, and uh... GAY GHOSTED?!?See omnystudio.com/listener for privacy information.

 "Is it possible to relax while watching Law & Order SVU? And why is Lady Gaga causing chaos in Austin high schools?" In this lively and emotionally resonant episode of The JB and Sandy Show, the crew dives into everything from pop culture obsessions to personal reflections on one of the most pivotal days in American history. Trisha shares a hilarious story about her daughter's stealthy attempt to score Lady Gaga tickets—even while at school—and the team reflects on Gaga's rise from meat dresses to undeniable musical talent. The conversation shifts to a powerful moment of remembrance as JB and Sandy recall being live on-air during the September 11 attacks, sharing how their voices became a source of comfort for thousands of Austinites. The episode also features a preview of their upcoming interview with Mackenzie Kelly, who's leading the charge against Austin's controversial new city logo.Key Moments:Trisha's daughter FaceTimes from school to buy Gaga tickets

Welcome back to The Snack – a lighter serving of Girls Gotta Eat. This week, we're talking about: Spit-Gate at the Eagles vs. Cowboys game Phillies Karen  Man getting stuck on the American flag  VMA highlights (Mariah, Gaga, Sabrina, etc.) The insane Unknown Number documentary Headlines: Luigi x Shein, Tr*mp's bday card to Epst*in, new hot celeb couples  Follow us on Instagram @girlsgottaeatpodcast, Ashley @ashhess, and Rayna @rayna.greenberg. Visit girlsgottaeat.com for more. Thank you to our partners this week: Function Health: Our first 1000 listeners get a $100 credit toward their membership at https://functionhealth.com/GGE or use code GGE100. Saks Fifth Avenue: Head to Saks Fifth Avenue or saks.com for inspiring ways to elevate your personal style. Bilt: Get points by paying rent at https://joinbilt.com/gge.  Skims: Get our favorite bras and underwear at https://skims.com/gge. Live Conscious: Get 15% off at https://liveconscious.com with code GGE. Addyi: Learn more at https://addyi.com/. 

See omnystudio.com/listener for privacy information.

See omnystudio.com/listener for privacy information.

Louie, Russ, and returning champ Reanna Cruz discuss the year in main pop girls before each sharing their personal top five Main Pop Girl Power Ranking for 2025 and putting their heads together for a collective top ten. Gaga? Addison? Doechii? Sabrina? PinkPantheress? Who will win?!?!Grab tix to Main Pop Girls on Oct. 3 at Parkside LoungeGrab tix to Gorgeous Gorgeous on Sept. 12 at The Sultan RoomJoin Pop Pantheon: All Access, Our Patreon Channel, for Exclusive Content and MoreShop Merch in Pop Pantheon's StoreFollow Pop Pantheon on InstagramFollow DJ Louie XIV on InstagramFollow DJ Louie XIV on Twitter

Lady Gaga takes over Scotiabank Arena with back-to-back shows, while Mike Tyson and Floyd Mayweather stun fans with a surprise fight announcement. Speed cameras are mysteriously being cut down across Toronto, and Ontario's minimum wage is set to rise. Plus, Maurie hits the TIFF red carpet with Ryan Reynolds and Colin Hanks for the emotional John Candy: I Like Me documentary.

The new Bachelorette is Taylor Frankie Paul from The Secret Lives of Mormon Wives and Brittany and Mike are annoyed. Kendall learns about her and is also not a fan of the pick. We brake it all down and Prince Harry has a sit-down with his Dad. Plus Mike is trying to get Gaga tickets and takes us Wayback!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Lady Gaga added more shows to her tour and she'll be coming to DC in 2026. New bachelorette announced and she's a social media star. The home that inspired the conjuring is going up on the auction block.Make sure to also keep up to date with ALL our podcasts we do below that have new episodes every week:The Thought ShowerLet's Get WeirdCrisis on Infinite Podcasts

She's an actual living, breathing Aussie legend, so having her inside the Emsolation Studios is a dream come true for Em and Michael as they chat with the incomparable Rhonda Burchmore. Get ready for some serious razzle-dazzle as Rhonda spills the tea on everything from Michael's offensive red carpet shirt, to her massive costume collection that covers her entire career (including pieces from her Sugar Babies appearance on London's West End with Mickey Rooney and Ann Miller, and the original Mamma Mia!). Em invites herself to tour her wardrobe and encourages Rhonda to create a retrospective exhibition too. You'll also hear her hilarious stories about tap dancing for Princess Diana, playing Sister Mary in Sister Act: The Musical, working on variety shows like The Don Lane and Mike Walsh Shows, the Tony Bartuccio Dancers and so much more. Plus Em pushes Rhonda to share her thoughts on why she's been missing from Carols by Candlelight, and commits to helping have her reinstated to the Carols line up. Then in our Sealed Section, on our premium service Emsolation Extra, Em defends Selena Gomez's mum, plus we Em-vestigate the VMAs and Mariah Carey's Vanguard Medley Performance from beginning to end and review 'Wednesday' and Gaga's 'The Dead Dance'. You can get access and listen to all of that and MORE for just $1.87 a week, or watch the full video of both episodes back to back via the Supercast website for $2.50 a week at emsolation.supercast.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Britney Spears may have dog poo just spread all across her house. Lady Gaga is extending the Mayhem Ball Tour and St. Paul is the FINAL STOP!!! Mike is freaking out. Plus, Mike and Kendall breakdown all the publationships you need to know and some you don't. Mike returns and shares stories of his time in Colorado. Plus, Quinn is in to recap the big Apple announcement day. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The MTV VMAs have come and gone and there was more than a few surprises! Did Ariana Grande get gongs just for showing up? Also, have a listen to the SHADE being thrown by a life-long diva of the music world! We also found out tha Gaga had somewhere better to be... cause she told us live on stage! See omnystudio.com/listener for privacy information.

Production 6A March 1-2 1982 The TARDIS lands in 1922 where Cranleigh Hall is being haunted by a mysterious figure and dead servants that only the Doctor apparently sees. Podcaster John S. Drew and writer/editor Jim Beard join forces once again to become the masters of time and space as they watch and review every single episode of the Classic Doctor Who series. In this episode, they are joined by artist Jerry Lange. Together, they discuss the stopping of the bickering among the crew, the obvious mystery, and the humor of the story. In addition, we have additional commentary from our Patreon subscribers who joined us to hear the podcast recorded live. Please make sure you are subscribed to our podcast via any of the major popular podcasting apps. You can write and comment or ask questions of us via email at thedoctorsbeardpodcast@gmail.com or by joining our Facebook community. Join our Patreon community where your sponsorship earns you early access to new episodes as well as exclusive content. Click on the link here to take you to the Patreon page.

Charlie Sheen bombshells. We're with Charlie and his drug dealer before his new documentary drops. What you never knew about the star posing arm in arm with ex Denise Richards. But why his brother Emilio and dad Martin Sheen didn't participate in the doc. Then, a “Today Show” host's heartbreak. Sheneille Jones opens up about losing her husband to brain cancer. Plus, Gaga, Mariah, and Sabrina! What to watch for at Sunday's VMAs. Only ET is with the host LL Cool J. And, Channing Tatum on the run. Our exclusive on the set of his new film, “Roofman”. Then, Pete Davidson's “Shark Tank” shocker. Why he's asking the sharks for half a million dollars. Plus, two game shows, two familiar faces. Jaleel White spills on the spicer new season of “The Flip Side”. And, Deborah Norville reveals why “The Perfect Line” is the trivia twist to watch. Then, from teen queen to pop icon, Debbie Gibson talks fame, stalkers, and stealing the spotlight at 17. She opens up to New Kid's Joey McIntyre. The teen idols as you've never seen them. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Tune in every Friday for more WOW Report.10) Rest in Perfection: Giorgio Armani @00:419) Trailer Park: Wuthering Heights @06:028) Hot Ticket: Hell's Kitchen @09:447) Hot Doc: Yacht Rock @18:586) Revisiting Oh, Hi @24:595) Gaga's Mayhem Ball @28:374) Blake Visits the Walmart Museum @35:423) Chloe Malle Takes Over for Anna Wintour at Vogue @39:332) Hot Ticket 2: Jinkx Monsoon in Oh, Mary! @42:511) The Wizard of OZ at the Sphere @47:00

Daily Dad Jokes (05 Sept 2025) The official Daily Dad Jokes Podcast electronic button now available on Amazon. The perfect gift for dad! Click here here to view! Email Newsletter: Looking for more dad joke humor to share? Then subscribe to our new weekly email newsletter. It's our weekly round-up of the best dad jokes, memes, and humor for you to enjoy. Spread the laughs, and groans, and sign up today! Click here to subscribe! Listen to the Daily Dad Jokes podcast here: https://dailydadjokespodcast.com/ or search "Daily Dad Jokes" in your podcast app. Interested in Business and Finance news? Then listen to our sister show: The Daily Business and Finance Show. Check out the website here or search "Daily Business and Finance Show" in your podcast app. Jokes sourced and curated from reddit.com/r/dadjokes. Joke credits: Harvard-23, iShitSkittles, CropDustinAround, zorbacles, tocath, Dr-Chibi, tvkyle, BlackSkurge, _them_fatale_, , SophieByers, dragonslumber, okamipiano, manpersondudeguymhm, this_onekid, ELTH3GR3AT, Kuriakon, TheRoyalBeeKing, VERBERD, k_woz1978 Subscribe to this podcast via: iHeartMedia Spotify iTunes Google Podcasts YouTube Channel Social media: Instagram Facebook Twitter TikTok Discord Interested in advertising or sponsoring our show? Contact us at mediasales@klassicstudios.com Produced by Klassic Studios using AutoGen Podcast technology (http://klassicstudios.com/autogen-podcasts/) Learn more about your ad choices. Visit megaphone.fm/adchoices

Daily Dad Jokes (05 Sept 2025) The official Daily Dad Jokes Podcast electronic button now available on Amazon. The perfect gift for dad! Click here here to view! Email Newsletter: Looking for more dad joke humor to share? Then subscribe to our new weekly email newsletter. It's our weekly round-up of the best dad jokes, memes, and humor for you to enjoy. Spread the laughs, and groans, and sign up today! Click here to subscribe! Listen to the Daily Dad Jokes podcast here: https://dailydadjokespodcast.com/ or search "Daily Dad Jokes" in your podcast app. Interested in Business and Finance news? Then listen to our sister show: The Daily Business and Finance Show. Check out the website here or search "Daily Business and Finance Show" in your podcast app. Jokes sourced and curated from reddit.com/r/dadjokes. Joke credits: Harvard-23, iShitSkittles, CropDustinAround, zorbacles, tocath, Dr-Chibi, tvkyle, BlackSkurge, _them_fatale_, , SophieByers, dragonslumber, okamipiano, manpersondudeguymhm, this_onekid, ELTH3GR3AT, Kuriakon, TheRoyalBeeKing, VERBERD, k_woz1978 Subscribe to this podcast via: iHeartMedia Spotify iTunes Google Podcasts YouTube Channel Social media: Instagram Facebook Twitter TikTok Discord Interested in advertising or sponsoring our show? Contact us at mediasales@klassicstudios.com Produced by Klassic Studios using AutoGen Podcast technology (http://klassicstudios.com/autogen-podcasts/) Learn more about your ad choices. Visit megaphone.fm/adchoices

Gaga had some good and some bad happen yesterday, and Taylor Swift may have already picked a wedding venue. Learn more about your ad choices. Visit megaphone.fm/adchoices

In which we talk Gaga's new music video, Vogue's new EIC, Karen Huger's prison release, Scooter Braun and Sydney Sweeney, A24 and Elden Ring, and Cardi B's legal win. JOIN US ON PATREON BONUS EPISODES + TV TALK EVERY WEEK About Eating For Free: Hosted by journalists Joan Summers and Matthew Lawson, Eating For Free is a weekly podcast that explores gossip and power in the pop culture landscape: Where it comes from, who wields it, and who suffers at the hands of it. Find out the stories behind the stories, as together they look beyond the headlines of troublesome YouTubers or scandal-ridden A-Listers, and delve deep into the inner workings of Hollywood's favorite pastime. The truth, they've found, is definitely stranger than any gossip. You can also find us on our website, Twitter, and Instagram. Any personal, business, or general inquires can be sent to eatingforfreepodcast@gmail.com  Joan Summers' Twitter, Instagram Matthew Lawson's Twitter, Instagram Skips:  Britney Spears smacks her butt and rubs her chest during racy dance in sheer bodysuit [Page Six] Kristen Doute blasts ‘disgusting' Golnesa ‘GG' Gharachedaghi over Brittany Cartwright pregnancy speculation [Page Six] ‘Real Housewives of Beverly Hills' Star Bozoma Saint John Is Engaged to Keely Watson [Us Weekly] Kim Kardashian Explains Why She ‘Doesn't Believe in Homework' [Us Weekly] Taylor Swift's First Post-Engagement Outfit Included a Preppy Fall Layer That's So Practical [People] Colman Domingo Says Prince and Paris Jackson Have Been 'Lovely' to Him in Making of Michael Jackson Biopic (Exclusive) [People] PARIS JACKSON REBUFFS COLMAN DOMINGO, SAYS MICHAEL JACKSON BIOPIC CONTAINS ‘FULL-BLOWN LIES' [Rolling Stone] Jennifer Aniston, 56, reveals what gives her anxiety... after admitting she is 'overwhelmed' at times [Daily Mail] Main Stories: Lady Gaga Drops Video for Surprise Single 'The Dead Dance' [Paper] New ‘Vogue' Head of Editorial Content Is a 'Proud' Nepo Baby [PAPER] Karen Huger Waves to Fans in Full Glam After Jail Release [PAPER] Wendy Williams Conservatorship Updates [Extra] SCOOTER BRAUN, SYDNEY SWEENEY IT'S OFFICIAL -- THEY'RE IN A SITUATIONSHIP!!!! [TMZ] Cardi B wins case filed by security guard who claimed rapper assaulted her [AP] Elden Ring Superfan Alex Garland Put Together a 160-Page Draft Script – With 40 Extra Pages of Images – to Convince Bandai Namco and FromSoftware to Let Him Direct the Movie [IGN]

Justin Bieber has made the announcement of a surprise album dropping Tonight, Lady Gaga has a very busy weekend coming up and had to cancel a show beforehand and Channing Tatum talks about losing weight, More details on the engagement of the century and the NFL wants Taylor because of course they do, plus Zoe and Harry are hooking up.Kendall tells all about Giorgio Armani who we lost earlier Today. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Mitch Marner opens up about leaving the Leafs over safety concerns, Lady Gaga drops a new song for Wednesday Season 2, Doug Ford goes off on Crown Royal, and Ridley Scott confirms Gladiator 3. Plus, viral hoaxes, celeb drama, scams, and a hot mic moment about immortality

We’ve got facts that will blow your tiny little minds – octopuses with three hearts, sharks older than trees, and yes, penguin pee frozen into Antarctic ice. Ricki and Tim are dropping the kind of trivia you’ll be bragging about at the pub. Then, Daniel Andrews has popped up in a very interesting spot, J-Lo has a fan losing it after she hit “follow,” and the Glossy’s are packed with Harry & Zoë hand-holding, Gaga’s mayhem, and Sabrina’s hair-pulling chaos. Plus, we’ll take you to Social’s Boot Camp – where Millennials get schooled on fonts, slang, and how not to embarrass yourself onlineSee omnystudio.com/listener for privacy information.

Thursday 9/4/25

Holly's Headlines 7a Wednesday 9/3/25

If you're not a Patreon Subscriber, you've never heard any of these moments before as they originated from our Patreon Show. A PHP Replay for Labor Day! (USA)See omnystudio.com/listener for privacy information.

Linktree: ⁠https://linktr.ee/Analytic⁠Join The Normandy For Additional Bonus Audio And Visual Content For All Things Nme+! Join Here: ⁠https://ow.ly/msoH50WCu0K⁠Join Analytic Dreamz on Notorious Mass Effect for an in-depth segment on Lady Gaga's The Dead Dance, releasing September 3, 2025, alongside Wednesday Season 2's final episodes. Announced at Spotify's Wednesday Graveyard Gala, the Tim Burton-directed video ties to Gaga's role as Rodolphe Lottwood. Analytic Dreamz covers the Roblox tease, Mayhem Ball Tour (Las Vegas to Europe), and rumored tracks like Can't Stop The High. With Katy Perry's praise and strategic timing, this single marks Gaga's bold return to the music spotlight.Support this podcast at — https://redcircle.com/analytic-dreamz-notorious-mass-effect/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

ty Durkin is celebrating a major milestone – Episode 50 of The Pop Corner! In this special episode, Matty shares heartfelt thanks to all the loyal listeners who've been with him since day one.

Netflix is 18 years, and it just earned its 1st box office hit with K-Pop Demon Hunter. Lady Gaga played ROBLOX over the weekend to promote her latest song. Former Eternals star has leaked out his contract from Marvel.Make sure to also keep up to date with ALL our podcasts we do below that have new episodes every week:The Thought ShowerLet's Get WeirdCrisis on Infinite Podcasts

Hello to our lovely coven, happy Wednesday! The girls had an eventful weekend and want to tell you all about it! Katie dishes about her trip over the pond to see Oasis, and all the trouble it took to get there. Dayna missed the Gaga show but she didn't stop at looking fabulous (pro tip: lots of lube). The girls also share their disdain for Matt Rife for purchasing Annabelle (rest in peace in advance my guy), they get nostalgic about mall culture, and ponder the existence of aliens. In need of something cute and cool for the summer? Get yourself or whoever's on your daddy list a tee, hoodie, or daddy hat from our store! Please support our show and show off your love for Disrespectfully by repping our official gear :) K Love ya bye! Thank you to our sponsors! Quince: Go to https://Quince.com/disrespectfully for free shipping on your order and 365-day returns ZipRecruiter: Try it FOR FREE at this exclusive web address: https://ZipRecruiter.com/DISRESPECT Rosetta Stone: Disrespectfully listeners can grab Rosetta Stone's LIFETIME Membership for 50% OFF! That's unlimited access to 25 language courses, for life! Visit https://www.rosettastone.com/disrespectfully     Shopify: Sign up for your $1-per-month trial and start selling today at https://Shopify.com/disrespectfully Connect with the Coven! Facebook: https://www.facebook.com/groups/1930451457469874 Reddit: https://www.reddit.com/r/disrespectfullypod/ Listen to us on Apple: https://podcasts.apple.com/us/podcast/disrespectfully/id1516710301 Listen to us on Spotify: https://open.spotify.com/show/0J6DW1KeDX6SpoVEuQpl7z?si=c35995a56b8d4038   Follow us on Social! Disrespectfully Instagram: https://www.instagram.com/disrespectfullypod Disrespectfully Tiktok: https://www.tiktok.com/@disrespectfullypod Katie Maloney Instagram: https://www.instagram.com/musickillskate Dayna Kathan Instagram: https://www.instagram.com/daynakathan Leah Glouberman Instagram: https://www.instagram.com/leahgsilberstein Allison Klemes Instagram: https://www.instagram.com/allisonklemes/ Buy our merch! https://disrespectfullypod.com/ Disrespectfully is an Envy Media Production.

Imogene Strauss is the Grammy Award-winning creative director known for her work with Charli XCX, Clairo, Demi Lovato, Tame Impala, and many more. We spoke with her from her home in Los Angeles about her going to see Gaga last night, her love of dance, her dad is a cool DJ, meeting David Bowie at a Killers concert, there are too many "assets" now, winning a Grammy, how not to be a creative director, a meeting with Miss Tina, the power of saying nah, she needs outfits, and she feels the need to camp now because of her new car. twitter.com/donetodeath twitter.com/themjeans howlonggone.com Learn more about your ad choices. Visit megaphone.fm/adchoices

This week on Sibling Rivalry, Bob and Monét get lyrical as they dive into the songs, singers, and moments they can't stop thinking about. They discuss whether great singing is fact or subjective, which queens are always doing a bit, and if AI content is getting harder to clock. Bob brings a new music game to the table, and they battle to sing songs with specific words in them. They talk jazz legends, their favorite Whitney songs, and what qualifies as a Great American Songbook entry (is WAP in there?). Plus, they debate Beyoncé's best awards show moment, revisit the Gaga album that caused drama among the Monsters, and try to prove who really knows every lyric—and who's the ultimate Little Monster. Want to see exclusive Sibling Rivalry Bonus Content? Head over to ⁠⁠⁠⁠⁠⁠⁠www.patreon.com/siblingrivalrypodcast⁠⁠⁠⁠⁠⁠⁠ to be the first to see our latest Sibling Rivalry Podcast Videos! @BobTheDragQueen @MonetXChange Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices⁠⁠⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices